Veracyte Inc

Veracyte Inc(VCYT)財務資料

$50.490

+2.398 (+4.75%)收盤時

VCYT 獲利能力與利潤率

Evaluating the bottom line, Veracyte, Inc. maintains a gross margin of 71.93%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 15.29%, while the net margin is 16.96%. These profitability ratios, combined with a Return on Equity (ROE) of 8.77%, provide a clear picture of how effectively VCYT converts its operational activities into shareholder value.

VCYT 同業比較

In the context of the broader market, VCYT competes directly with industry leaders such as PLSE and NVST. With a market capitalization of $3.85B, it holds a leading position in the sector. When comparing efficiency, VCYT's gross margin of 71.93% stands against PLSE's 37.10% and NVST's 56.71%. Such benchmarking helps identify whether Veracyte, Inc. is trading at a premium or discount relative to its financial performance.

Veracyte Inc 財務表現

Veracyte has demonstrated strong financial performance with a gross margin of 71.93% in Q2 2026 and a net income of $25,490,000 for the same quarter, indicating effective cost management and revenue generation.

Financials

FY2026Q2
YoY:
+15.49%
150.32M
Total Revenue
FY2026Q2
YoY:
+50.82%
22.98M
Operating Profit
FY2026Q2
YoY:
-2701.02%
25.49M
Net Income after Tax
FY2026Q2
YoY:
-3200.00%
0.31
EPS - Diluted
FY2026Q2
YoY:
+32.95%
42.97M
Free Cash Flow
FY2026Q2
YoY:
+5.02%
71.93
Gross Profit Margin - %
FY2026Q2
YoY:
+68.61%
29.54
FCF Margin - %
FY2026Q2
YoY:
-2361.33%
16.96
Net Margin - %
FY2026Q2
YoY:
+291.52%
8.77
ROIC

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易